RGRX - RegeneRx Biopharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.265
+0.015 (+6.000%)
At close: 3:57PM EST
Stock chart is not supported by your current browser
Previous Close0.250
Open0.254
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.250 - 0.265
52 Week Range0.140 - 0.380
Volume110,137
Avg. Volume105,904
Market Cap29.094M
Beta1.72
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
    Capital Cube2 months ago

    RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis RegeneRx Biopharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of RegeneRx Biopharmaceuticals, Inc. – MediWound Ltd., XOMA Corporation, Novartis AG Sponsored ADR, Akorn, Inc., Johnson & Johnson, Rigel Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc. Class A, Mateon Therapeutics, Inc. ... Read more (Read more...)

  • RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017
    Capital Cube4 months ago

    RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017

    Categories: Yahoo FinanceGet free summary analysis RegeneRx Biopharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of RegeneRx Biopharmaceuticals, Inc. – MediWound Ltd., XOMA Corporation, Akorn, Inc., Mateon Therapeutics, Inc., Rigel Pharmaceuticals, Inc. and Sucampo Pharmaceuticals, Inc. Class A (MDWD-US, XOMA-US, AKRX-US, MATN-US, RIGL-US and ... Read more (Read more...)

  • RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017
    Capital Cube8 months ago

    RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis RegeneRx Biopharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of RegeneRx Biopharmaceuticals, Inc. – MediWound Ltd., XOMA Corporation, Novartis AG Sponsored ADR, Sevion Therapeutics, Inc., Akorn, Inc., Johnson & Johnson, Rigel Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc. Class A, ... Read more (Read more...)

  • RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 31, 2017
    Capital Cube10 months ago

    RegeneRx Biopharmaceuticals, Inc. :RGRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 31, 2017

    Categories: Yahoo Finance Get free summary analysis RegeneRx Biopharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of RegeneRx Biopharmaceuticals, Inc. – MediWound Ltd., XOMA Corporation, Sevion Therapeutics, Inc., Akorn, Inc., Rigel Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc. Class A, Mateon Therapeutics, Inc. and Capstone Therapeutics Corp. ... Read more (Read more...)